Your browser doesn't support javascript.
loading
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.
Huhn, Konstantin; Bayas, Antonios; Doerck, Sebastian; Frank, Benedikt; Gerbershagen, Kathrin; Hellwig, Kerstin; Kallmann, Boris; Kleinschnitz, Christoph; Kleiter, Ingo; Lee, De-Hyung; Limmroth, Volker; Mäurer, Mathias; Meuth, Sven; Rieckmann, Peter; Ruck, Tobias; Gold, Ralf; Linker, Ralf A.
Afiliación
  • Huhn K; Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nürnberg, Germany. Konstantin.Huhn@uk-erlangen.de.
  • Bayas A; Department of Neurology, Klinikum Augsburg, Augsburg, Germany.
  • Doerck S; Department of Neurology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
  • Frank B; Department of Neurology, University Hospital Essen, Essen, Germany.
  • Gerbershagen K; Department of Neurology, Klinikum Köln-Merheim, Cologne, Germany.
  • Hellwig K; Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany.
  • Kallmann B; MS Center Bamberg, Bamberg, Germany.
  • Kleinschnitz C; Department of Neurology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
  • Kleiter I; Department of Neurology, University Hospital Essen, Essen, Germany.
  • Lee DH; Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany.
  • Limmroth V; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke gGmbH, Milchberg 21, 82335, Berg, Germany.
  • Mäurer M; Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nürnberg, Germany.
  • Meuth S; Department of Neurology, Klinikum Köln-Merheim, Cologne, Germany.
  • Rieckmann P; Department of Neurology, Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany.
  • Ruck T; Department of Neurology, Julius-Spital Würzburg, Würzburg, Germany.
  • Gold R; Department of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Linker RA; MS Center Bamberg, Bamberg, Germany.
J Neurol ; 265(7): 1521-1527, 2018 Jul.
Article en En | MEDLINE | ID: mdl-29696498
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod / Alemtuzumab / Antineoplásicos Inmunológicos / Inmunosupresores Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod / Alemtuzumab / Antineoplásicos Inmunológicos / Inmunosupresores Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania